180 related articles for article (PubMed ID: 6743569)
1. Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders.
Hibbin JA; Njoku OS; Matutes E; Lewis SM; Goldman JM
Br J Haematol; 1984 Jul; 57(3):495-503. PubMed ID: 6743569
[TBL] [Abstract][Full Text] [Related]
2. Differences among myeloproliferative disorders in the behavior of their restricted progenitor cells in culture.
Croizat H; Amato D; McLeod DL; Eskinazi D; Axelrad AA
Blood; 1983 Sep; 62(3):578-84. PubMed ID: 6603877
[TBL] [Abstract][Full Text] [Related]
3. Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin-3.
Kobayashi S; Teramura M; Hoshino S; Motoji T; Oshimi K; Mizoguchi H
Br J Haematol; 1993 Apr; 83(4):539-44. PubMed ID: 7686030
[TBL] [Abstract][Full Text] [Related]
4. Primary polycythaemia, essential thrombocythaemia and myelofibrosis--three facets of a single disease process?
Adams JA; Barrett AJ; Beard J; McCarthy DM
Acta Haematol; 1988; 79(1):33-7. PubMed ID: 3124458
[TBL] [Abstract][Full Text] [Related]
5. Endogenous erythroid colony formation in myeloproliferative diseases does not depend on T cells.
Robak T; Hast R; Goldman JM
Exp Hematol; 1986 Mar; 14(3):197-201. PubMed ID: 3485053
[TBL] [Abstract][Full Text] [Related]
6. Circulating pluripotent haemopoietic cells in patients with myeloproliferative disorders.
Douer D; Fabian I; Cline MJ
Br J Haematol; 1983 Jul; 54(3):373-81. PubMed ID: 6574788
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of circulating megakaryocyte progenitors (CFU-MK) in patients with primary myelofibrosis.
Han ZC; Briere J; Nedellec G; Abgrall JF; Sensebe L; Parent D; Guern G
Eur J Haematol; 1988 Feb; 40(2):130-5. PubMed ID: 3345826
[TBL] [Abstract][Full Text] [Related]
8. Endogenous megakaryocyte colonies from peripheral blood in precursor cell cultures of patients with myeloproliferative disorders.
Battegay EJ; Thomssen C; Nissen C; Gudat F; Speck B
Eur J Haematol; 1989 Apr; 42(4):321-6. PubMed ID: 2656291
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic evidence for a clonal disorder involving CFU-GEMM, BFU-E and CFU-C in patients with myeloproliferative disorders.
Sugiyama H; Ichiba S; Okuno Y; Takahashi T; Imura H; Nakamura K; Iho S; Hoshino T; Okada T; Furukawa H
Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1022-32. PubMed ID: 2588952
[TBL] [Abstract][Full Text] [Related]
10. Circulating hematopoietic progenitor cells predict survival in patients with myelofibrosis with myeloid metaplasia.
Sagaster V; Jäger E; Weltermann A; Schwarzinger I; Gisslinger H; Lechner K; Geissler K; Oehler L
Haematologica; 2003 Nov; 88(11):1204-12. PubMed ID: 14607748
[TBL] [Abstract][Full Text] [Related]
11. Effects of recombinant alpha and gamma interferons on the in vitro growth of circulating hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM) from patients with myelofibrosis with myeloid metaplasia.
Carlo-Stella C; Cazzola M; Gasner A; Barosi G; Dezza L; Meloni F; Pedrazzoli P; Hoelzer D; Ascari E
Blood; 1987 Oct; 70(4):1014-9. PubMed ID: 3115331
[TBL] [Abstract][Full Text] [Related]
12. Numbers of colony-forming progenitors in patients with systemic mastocytosis: potential diagnostic implications and comparison with myeloproliferative disorders.
Jordan JH; Jäger E; Sperr WR; Schwarzinger I; Födinger M; Fritsche-Polanz R; Ohler L; Geissler K; Valent P
Eur J Clin Invest; 2003 Jul; 33(7):611-8. PubMed ID: 12814399
[TBL] [Abstract][Full Text] [Related]
13. Serum erythropoietin (ESF) levels and erythroid progenitors (CFU-Es) of patients with chronic myeloproliferative disorders.
Fukushima Y; Miura I; Takahashi T; Fukuda M; Yoshida K; Yamaguchi A; Miura AB
Tohoku J Exp Med; 1984 Apr; 142(4):399-407. PubMed ID: 6588639
[TBL] [Abstract][Full Text] [Related]
14. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
15. Circulating granulocyte and macrophage progenitor cells in primary and secondary myelofibrosis.
Wang JC; Cheung CP; Ahmed F; Steier W; Tobin MS
Br J Haematol; 1983 Jun; 54(2):301-7. PubMed ID: 6849843
[TBL] [Abstract][Full Text] [Related]
16. Circulating haematopoietic progenitors in myelofibrosis.
Partanen S; Ruutu T; Vuopio P
Scand J Haematol; 1982 Oct; 29(4):325-30. PubMed ID: 7178838
[TBL] [Abstract][Full Text] [Related]
17. Megakaryocytes in cubital venous blood in patients with chronic myeloproliferative diseases.
Tinggaard Pedersen N; Laursen B
Scand J Haematol; 1983 Jan; 30(1):50-8. PubMed ID: 6573016
[TBL] [Abstract][Full Text] [Related]
18. Megakaryocyte progenitors in the bone marrow and peripheral blood of patients with myeloproliferative diseases.
Grossi A; Vannucchi AM; Rafanelli D; Vannucchi L; Ferrini PR
Am J Hematol; 1987 Aug; 25(4):371-6. PubMed ID: 3497577
[TBL] [Abstract][Full Text] [Related]
19. [Megakaryocytopoiesis in myeloproliferative disorders].
Podolak-Dawidziak M
Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
[No Abstract] [Full Text] [Related]
20. Circulating haemopoietic progenitor cells in primary and secondary myelofibrosis: relation to collagen and reticulin fibrosis.
Colović MD; Wiernik PH; Janković GM; Vidović AD; Janosević S; Basara NM
Eur J Haematol; 1999 Mar; 62(3):155-9. PubMed ID: 10089892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
